Connect your AI

Medline, Inc. MDLN Price / sales

Price / sales at other companies

Becton, Dickinson and CompanyBDX

2.1×-1.2×

Cardinal HealthCAH

0.2×0.0×

McKessonMCK

0.3×0.0×

StrykerSYK

5×-1.1×

West Pharmaceutical ServicesWST

5.6×0.0×

GE HealthCare TechnologiesGEHC

1.5×-0.3×

Other financials

Income statement

Revenue$7.4B+10.7%

Gross profit$1.8B+0.9%

Operating income$422.0M-26.1%

Net income$239.0M-25.1%

EPS (diluted)$0.16—

Balance sheet

Cash & equivalents$2.2B+166%

Total debt$12.6B—

Total equity$11.3B—

Total assets$39.0B—

Cash flow

Operating cash flow$412.0M-39.6%

CapEx$96.0M-2.0%

Free cash flow$316.0M-45.9%

Valuation

Market cap$30.8B—

Enterprise value$41.12B—

P/E36.6×—

Profitability

Gross margin27.4%+1.5pp

Operating margin8.5%+2.3pp

Net margin4.6%+2.7pp

Returns & leverage

Return on equity7.7%—

Debt / equity1.1×—

Current ratio4.4×—